Validation of a pXO2-A PCR assay to explore diversity among Italian isolates of Bacillus anthracis strains closely related to the live, attenuated Carbosap vaccine.
Several circulating Bacillus anthracis strains isolated in Italy and belonging to the A1.a cluster, genotype 3 (A1.a-3) are genotypically indistinguishable from Carbosap, a live attenuated vaccine strain, containing both pXO1 and pXO2 plasmids. The genotype was assessed by using eight-locus multilocus variable-number tandem repeat analysis. We describe here the use of a ninth locus able to explore variability among strains that have the same genotype. It is important to be able to genotype the wild isolate of B. anthracis strains from outbreaks of anthrax in areas where Carbosap vaccination of cattle and sheep is common practice. A total of 27 representative field strains isolated in Italy and four vaccinal strains, namely, Carbosap, Sterne, Pasteur I, and Pasteur II, were characterized by a ninth marker, called pXO2-A. Twenty-three field strains were genotype 3 and therefore identical to Carbosap. The marker was in the pXO2 plasmid and is based on the polymorphism of the already-known VX2-3 locus. Detection was obtained by PCR with fluorescence-labeled forward primers in order to produce appropriate fragments for capillary electrophoresis with an ABI 310 genetic analyzer. Genetic relationships showed heterogeneity in all of the examined samples. Interestingly, with respect to genotype 3, samples grouped into eight different subtypes, A to H, and the subtype G, had only two samples indistinguishable from Carbosap. The results of the present study confirm the validity of a hierarchical progressive protocol for discrimination among closely related isolates.
Muscillo
M
M
Department of Environment and Primary Prevention, Istituto Superiore Sanità Roma, Rome. muscillo@iss.it
La Rosa
G
G
Sali
M
M
De Carolis
E
E
Adone
R
R
Ciuchini
F
F
Fasanella
A
A
D000818:Animals; D000881:Anthrax / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D022122:Anthrax Vaccines / Q000008:administration & dosage; D001408:Bacillus anthracis / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D016667:Bacterial Capsules / Q000235:genetics / Q000378:metabolism; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism; D002417:Cattle; D002418:Cattle Diseases / Q000382:microbiology / Q000517:prevention & control; D014644:Genetic Variation; D015511:Goat Diseases / Q000382:microbiology / Q000517:prevention & control; D006041:Goats; D007558:Italy; D010957:Plasmids / Q000235:genetics*; D016133:Polymerase Chain Reaction / Q000379:methods*; D012756:Sheep; D012757:Sheep Diseases / Q000382:microbiology / Q000517:prevention & control; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014774:Virulence
D022122:Anthrax Vaccines; D001427:Bacterial Toxins; D014613:Vaccines, Attenuated